Daktari Diagnostics, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Daktari Diagnostics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2008. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $2.7 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $22 million sold in a notice filed in 2016.
Daktari Diagnostics at a glance
What does Daktari Diagnostics do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $2.7 million in total (2014 to 2017). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $22.5 million sold (2016).
Frequently asked questions about Daktari Diagnostics
Where is Daktari Diagnostics headquartered?
Daktari Diagnostics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Daktari Diagnostics do?
Daktari Diagnostics, Inc. is a biotechnology company.
When was Daktari Diagnostics founded?
The earliest incorporation on record for Daktari Diagnostics, Inc. is in 2008, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences